Take BREVENA’s Macro B Complex Skincare Challenge
September 4, 2015
BREVENA Skin Care
Beautiful skin is within reach! The Balancing Act offers solutions.
There’s no question– your diet and alcohol can wreak havoc on your skin. But so does smoking, stress and the environment. That’s why it’s important to have a strong outer barrier such as a good moisturizer, which acts as an invisible shield against these skin assailants. Skin hydration is key. Are you ready to reclaim your beautiful skin? Skin experts –Barbara Klein, President of the luxury skincare cosmetics company — BREVENA Laboratories… and Plastic Surgeon, Dr. Debra Reilly join us, for a great discussion on skincare—and how BREVENA’s ingredients can help you reclaim your beautiful skin.
BREVENA products are the only cosmetic skincare products to have evolved from over 20 years of successful medial use—treating and healing acute burns and severely traumatized skin, with their proprietary Macro β Complex technology. Macro β Complex rejuvenates your skin to by locking in moisture, diminishing fine lines, minimizing redness and soothing itch. We’re talking intense hydration! Get ready to put your best face forward! Skin Matters. Love Your Skin.™
Special Offer for Balancing Act Viewers:
SAVE 20% and FREE SHIPPING with promo code: OLGA at brevena.com
[ct_button id=”button_6″ size=”small” link=”http://bit.ly/1Kg2h2n” icon=”” bg_color=”#f3c9ff”]Redeem Coupon[/ct_button]
Bringing the best tips from the experts in Atlanta in business, beauty, wealth management, child healthcare, car shopping, and more. Each year, Atlanta’s Women’s Entrepreneurship Initiative selects 15 local female entrepreneurs for a 15-month business training program. We meet women who have grown their companies, created jobs, and broke through the glass ceiling. With some […]
iMCD is the deadliest subtype of Castleman disease. Approximately one third of patients die within five years of diagnosis, and another third die within 10 years if not treated.
There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades.